Dachaigh › Galar Depressive Mòr › Illinois
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Illinois
Tha 20 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann an Illinois.
Bailtean ann an Illinois
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Rush University, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06793397A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Uptown Research Institute, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07592689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Chicago Research Center, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07573176A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Charter Research - Chicago, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Endeavor Health Evanston Hospital, Evanston
A’ fastadhÌre 3
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07227454Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Northwestern University, Chicago
- Baber Research Group, Naperville
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Chicago Research Center, Chicago
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Advanced Quality Medical Research, Orland Park
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Chicago
- Draig Clinical Site, Skokie
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Rush University Medical Center, Chicago
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06423430A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- EmVenio Research, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
- Amr Conventions Research /ID# 277547, Warrenville
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT07276997Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
A’ fastadh
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05051618A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research LLC, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 40 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06740383Study of ALTO-300 in MDD
- Site 310, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Iuch 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Chicago
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 23 Faoi 2025 · NCT06223880Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.